Literature DB >> 14597481

Free secretory component from cystic fibrosis sputa displays the cystic fibrosis glycosylation phenotype.

Lindsay J Marshall1, Beatrice Perks, Kathleen Bodey, Ranjan Suri, Andrew Bush, Janis K Shute.   

Abstract

Secretory IgA contributes to humoral defense mechanisms against pathogens targeting mucosal surfaces, and secretory component (SC) fulfills multiple roles in this defense. The aims of this study were to quantify total SC and to analyze the form of free SC in sputa from normal subjects, subjects with asthma, and subjects with cystic fibrosis (CF). Significantly higher levels of SC were detected in CF compared with both other groups. Gel filtration chromatography revealed that SC in CF was relatively degraded. Free SC normally binds interleukin (IL)-8 and inhibits its function. However, in CF sputa, IL-8 binding to intact SC was reduced. Analysis of the total carbohydrate content of free SC signified overglycosylation in CF compared with normal subjects and subjects with asthma. Monosaccharide composition analysis of free SC from CF subjects revealed overfucosylation and undersialylation, in agreement with the reported CF glycosylation phenotype. SC binding to IL-8 did not interfere with the binding of IL-8 to heparin, indicating distinct binding sites on IL-8 for negative regulation of function by SC and heparin. We suggest that defective structure and function of SC contribute to the characteristic sustained inflammatory response in the CF airways.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14597481     DOI: 10.1164/rccm.200305-619OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  5 in total

Review 1.  Secretory Immunoglobulin A Immunity in Chronic Obstructive Respiratory Diseases.

Authors:  Charlotte de Fays; François M Carlier; Sophie Gohy; Charles Pilette
Journal:  Cells       Date:  2022-04-13       Impact factor: 7.666

2.  Human neutrophil peptides and phagocytic deficiency in bronchiectatic lungs.

Authors:  Stefanos Voglis; Kieran Quinn; Elizabeth Tullis; Mingyao Liu; Melanie Henriques; Celia Zubrinich; Oscar Peñuelas; Holman Chan; Frances Silverman; Vera Cherepanov; Neil Orzech; Aye Aye Khine; André Cantin; Arthur S Slutsky; Gregory P Downey; Haibo Zhang
Journal:  Am J Respir Crit Care Med       Date:  2009-04-30       Impact factor: 21.405

3.  Lung immunoglobulin A immunity dysregulation in cystic fibrosis.

Authors:  Amandine M Collin; Marylène Lecocq; Sabrina Noel; Bruno Detry; François M Carlier; Frank Aboubakar Nana; Caroline Bouzin; Teresinha Leal; Marjorie Vermeersch; Virginia De Rose; Lucile Regard; Clémence Martin; Pierre-Régis Burgel; Delphine Hoton; Stijn Verleden; Antoine Froidure; Charles Pilette; Sophie Gohy
Journal:  EBioMedicine       Date:  2020-09-11       Impact factor: 8.143

4.  Mucosal humoral immunity in cystic fibrosis - a tangled web of failed proteostasis, infection and adaptive immunity.

Authors:  Richard B Moss
Journal:  EBioMedicine       Date:  2020-09-21       Impact factor: 8.143

Review 5.  Immunoglobulin A Mucosal Immunity and Altered Respiratory Epithelium in Cystic Fibrosis.

Authors:  Sophie Gohy; Alexandra Moeremans; Charles Pilette; Amandine Collin
Journal:  Cells       Date:  2021-12-20       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.